Outcomes of De Vega versus Biodegradable Ring Annuloplasty in the Surgical Treatment of Tricuspid Regurgitation (Mid-term Results)
Purpose: The aim of this study was to compare De Vega semicircular annuloplasty and a new biodegradable ring annuloplasty technique in patients requiring surgical intervention for tricuspid valve disease with concomitant disease of the mitral valve.
Methods: Between January 2004 and May 2008, 129 consecutive patients underwent annuloplasty procedures to correct tricuspid valve regurgitation during a concomitant mitral valve operation requiring replacement. Additionally, 24 patients underwent aortic valve replacement (AVR), 11 underwent coronary artery bypass grafting (CABG), 5 underwent AVR plus CABG, 3 underwent mitral valve replacement plus atrial septal defect (ASD) closure, and 2 underwent ASD closure. The patients in this study were assigned to 2 groups: Kalangos ring annuloplasty was performed in 67 patients (group 1), and De Vega semicircular annuloplasty was performed in the remaining 62 patients (group 2).
Results: Both tricuspid valve repair techniques produced a low rate of complications; however, the number of patients who developed residual tricuspid regurgitation was significantly lower in group 1.
Conclusion: The biodegradable ring annuloplasty technique may be used easily and safely in moderate and severe cases of tricuspid regurgitation; however, larger clinical series are necessary to confirm our promising results.
Blackstone EH, Kirklin JW, Pacifico AD. 1979. Decision-making in repair of tetralogy of Fallot based on intraoperative measurements of pulmonary arterial outflow tract. J Thorac Cardiovasc Surg 77:526-32.nBoyd AD, Engelman RM, Isom OV, Reed GE, Spencer FC. 1974. Tricuspid annuloplasty: five and one-half years' experience with 78 patients. J Thorac Cardiovasc Surg 68:344-51.nBreyer RH, McClenathan JH, Michaels LL, McIntosh CL, Morrow AG. 1976. Tricuspid regurgitation. A comparison of nonoperative management, tricuspid annuloplasty and tricuspid valve replacement. J Thorac Cardiovasc Surg 72:867-74.nCarpentier A, Deloche A, Hanania G, et al. 1974. Surgical management of acquired tricuspid valve disease. J Thorac Cardiovasc Surg 67:53-65.nCome PC, Riley MF. 1985. Tricuspid annular dilatation and failure of tricuspid leaflet coaptation in tricuspid regurgitation. Am J Cardiol 55:599-601.nDe Vega NG. 1972. Selective, adjustable and permanent annuloplasty. An original technic for the treatment of tricuspid insufficiency [in Spanish]. Rev Esp Cardiol 25:555-6.nEge E, Paç M. 2002. Tricuspid ve Pulmoner kapak hastaliklarinda cerrahi yakla?im. T Klin Kardiyol 15:136-41.nHaerten K, Sepiel L, Loogen F, Herzer J. 1978. Hemodynamic studies' after DeVega's tricuspid annuloplasty. Circulation 58:I28-33.nKalangos A, Sierra J, Vala D, et al. 2006. Annuloplasty for valve repair with a new biodegradable ring: an experimental study. J Heart Valve Dis 15:783-90.nKay JH, Maselli-Campagna G, Tsuji KK. 1965. Surgical treatment of tricuspid insufficiency. Ann Surg 162:53-8.nKay JH. 1992. Surgical treatment of tricuspid insufficiency. Ann Thorac Surg 53:1132-3.nKazaz M, Celkan MA, Ustunsoy H, Ba?pinar O. 2005. Mitral annuloplasty with biodegradable ring for infective endocarditis: a new tool for the surgeon for valve repair in childhood. Interact Cardiovasc Thorac Surg 4:378-80.nKing RM, Schaff HV, Danielson GK, et al. 1984. Surgery for tricuspid regurgitation late after mitral valve replacement. Circulation 70:I193-7.nPasque M, Williams WG, Coles JG, Trusler GA, Freedom RM. 1987. Tricuspid valve replacement in children. Ann Thorac Surg 44:164-8.nSimon R, Oelert H, Borst HG, Lichtlen PR. 1980. Influence of mitral valve surgery on tricuspid incompetence concomitant with mitral valve disease. Circulation 62:I152-7.nUluçay A, Tatli E. 2008. Myokart performans indeksi. Anadolu Kardiyol Derg 8:143-8.nYavuz S. 2007. Should stitch annuloplasty really be abandoned for developed flexible prosthetic band or ring in functional tricuspid regurgitation? Interact Cardiovasc Thorac Surg 6:736.n